| Stage | GBX | % of rev | WAB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $591M | 100.00% | $3.1B | 100.00% | WAB ×5.28 |
| Gross profit | $80M | 13.50% | $1.2B | 37.31% | WAB +23.8pp |
| Operating income | $26M | 4.31% | $625M | 20.03% | WAB +15.7pp |
| Pre-tax income | $6M | 1.05% | $557M | 17.85% | WAB +16.8pp |
| Net income | $13M | 2.18% | $411M | 13.17% | WAB +11.0pp |
| Stage | GBX | WAB | Gap · A − B |
|---|---|---|---|
| Revenue | $591M100.00% | $3.1B100.00% | WAB ×5.28 |
| Gross profit | 13.50%$80M | 37.31%$1.2B | WAB +23.8pp |
| Operating income | 4.31%$26M | 20.03%$625M | WAB +15.7pp |
| Pre-tax income | 1.05%$6M | 17.85%$557M | WAB +16.8pp |
| Net income |
None
No disclosed counterparties: GBX.
| 2.18%$13M |
| 13.17%$411M |
| WAB +11.0pp |